Latest filing published 06 Aug 2021 for Rossari Biotech Limited, €9,435.
Filing timeline
BuySaleAadesh Sakpal: trading record in brief
All filings by Aadesh Sakpal on record concern Rossari Biotech Limited, in the capacity of chief executive. In total, 2 filings cover trades dated from 17 July 2021 to 4 August 2021.
Every open-market trade on record is a sale: 1 sale worth €9,435. Other entries cover 1 share grant.
Most recently, on 6 August 2021, the filings show an open-market sale worth €9,435 in Rossari Biotech Limited. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Companies and markets linked to Aadesh Sakpal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600 shares@ ₹1,382.220.0000% mcap41.6% of flowEquity SharesSEBI:e726c5056a320b69c718d22c2cab508d9ee2610b
- 1,000 shares@ ₹1,167.450.0001% mcap58.4% of flowEquity SharesSEBI:d98abcd759213b4a5c285e1c1c24f70830829c2dCanonical exit: 15 Oct 2021 (T+90)
2 of 2 declarations